Clinical Trials Sponsored by Cemka-Eval

Total 282 results

Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma. (GABRINOX)

Metastatic Pancreatic Adenocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) (BIORISE)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL) (HYPNOVAL)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer (BREGO)

Digestive Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan (SIRINOX)

Digestive Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors (NEXIRI2)

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine (THERAPY)

Pancreatic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

A Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib in Multiple Non Operable Brain Metastases (RAPIBE)

Brain Metastases

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma (GATE 1)

Metastatic Pancreatic Adenocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Patients With Brain Metastases From HER2-positive Breast Cancer (BIRTH)

HER2-positive Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Safety and Efficacity of NFL101 as Tobacco Therapy (CESTO)

Smoking

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer

Prostate Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle
Bayer

Completed

Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS Mutation (NEXIRI)

Metastatic Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle
Novartis

Completed

Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics (MONAGE)

Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Versus On-request (VENUS)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Evaluation of the Impact of Multidisciplinary Oncosexology Management Associated With Photobiomodulation on Sexual Quality of Life in Women With Breast Cancer (EVABIOSEIN)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer (PANC-O-MICS)

Pancreas Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging (MR-O-MICS)

High Grade Serous Ovarian Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology (SAHARA-04)

Breast Cancer

France
Jennifer Eva Selfridge

Recruiting

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Colorectal Cancer | Hodgkin Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Plasma Cell Myeloma | Hematologic Malignancy | Rectum Cancer | Myeloproliferative Syndrome

United States
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

A Clinico-biological Database in Cachexia in Patients With Colon Cancer (BCB Cachexie)

Colon Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment (SEQUOIA)

Anxiety | Anal Cancer | HPV | Sexuality | Psychologic Stress

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients (GABRINOX2)

Metastatic Pancreatic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work (VISIBILITE)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET (ReLUTH)

Progressive Disease | Neuroendocrine Tumors | Intestinal Well Differentiated Endocrine Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer (GABRINOX-ART)

Locally Advanced Pancreatic Adenocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery (MACS)

Breast Cancer | Surgery

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life (PRAVACUR-02)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE) (BCB)

Cancer | Peritoneal Carcinosis

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department (BCB RIV)

Prostate Cancer | Neuroendocrine Tumors | Thyroid Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers (MICARE)

Rectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of a Clinical and Biological Database in Rectum Cancer (BCBRectum)

Rectal Neoplasms

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers (BCBOvaire)

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Ovarian Epithelial

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Clinical and Biological Database in Colon Cancer and Colic Tumors (BCBCOLON)

Cancer Colon

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Memory Perception Assessment in Central/Non-central Nervous System Cancers (PROMESSE)

Glioma | Healthy | Breast Cancer | Glioblastoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of Clinical and Biological Database (BCBInstitut)

Sarcoma | Breast Cancer | Gynecologic Cancer | Digestive Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors (PLATON)

Anemia | Unspecified Adult Solid Tumor, Protocol Specific

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Clinical Database of Colorectal Robotic Surgery (ROBOT CR)

Crohn Disease | Ulcerative Colitis | Diverticulitis | Rectal Prolapse | Polyposis | Colorectal Tumor | Benign Colorectal Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Robotic Low Rectum Anterior Resection (GROG-R01)

Rectum Cancer

France, Belgium, Monaco
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Psychological Experience of Discontinuation an Early Phase Treatment by Patients (VRAIMENT)

Cancer | Psychological Distress

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer (PRAVAPREV-01)

Breast Cancer

Monaco, France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy (LEANOX)

Stage III Colon Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy (IMMUVIX)

Cervical Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC (NIPOX)

Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer (MSPD)

Advanced Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients

Breast Cancer | Prostate Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Sexual Quality of Life of Patients With Gynecologic Cancer Treated With Brachytherapy. (Gyn&Co)

Cervical Cancer | Pelvic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer (FLUOCAR-1)

Peritoneal Carcinomatosis

France

Clinical Trials Sponsored by Cemka-Eval

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations